Compare HNNA & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HNNA | COEP |
|---|---|---|
| Founded | 1989 | 2017 |
| Country | United States | United States |
| Employees | N/A | 6 |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.0M | 91.2M |
| IPO Year | N/A | N/A |
| Metric | HNNA | COEP |
|---|---|---|
| Price | $10.10 | $16.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.8K | ★ 60.9K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | ★ 5.57% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.77 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.90 | $6.80 |
| 52 Week High | $13.19 | $21.41 |
| Indicator | HNNA | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 59.30 | 72.18 |
| Support Level | $9.66 | $13.77 |
| Resistance Level | $10.33 | $19.19 |
| Average True Range (ATR) | 0.14 | 1.15 |
| MACD | 0.03 | 0.47 |
| Stochastic Oscillator | 90.08 | 87.62 |
Hennessy Advisors Inc is an investment management company that manages and markets open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, multi-asset sectors, specialty products, and fixed income products. The company earns revenues mainly from investment advisory services and secondarily from shareholder services. Advisory services include managing each fund's portfolio in line with its investment objectives, monitoring compliance and performance, overseeing sub-advisors and other service providers, and handling marketing, distribution, and regulatory reporting. Shareholder services cover investor support and coordination with the fund service provider, with all related fees based on the funds' average daily net asset values.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.